nervous system
• reduced accumulation of recombinant alpha-synuclein preformed fibrils following a 3-month incubation period compared to similarly treated wild-type controls
|
homeostasis/metabolism
• following 3-month incubation period with recombinant alpha-synuclein preformed fibrils loss of TH-positive neurons and fiber degeneration is reduced compared to similarly treated wild-type controls
• spread of phospho-ser129 alpha-synuclein pathology in key brain regions at 6 months after treatment is reduced compared to similarly treated wild-type controls
|